We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vulcan Materials
VMC
$36.5B
| $21.5M | 0.05% |
+144,783
| New | +$20.6M |
|
402
Louisiana-Pacific
LPX
$5.31B
| $21.3M | 0.05% |
574,046
-2,283,831
| -80% | -$76.5M |
|
|
TPTX
403
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $21.3M | 0.05% |
175,000
-25,000
| -13% | -$2.74M |
|
|
SWTX
404
DELISTED
SpringWorks Therapeutics
SWTX
| $21.3M | 0.05% |
+294,000
| New | +$18.9M |
|
405
Keysight
KEYS
$57.6B
| $21.3M | 0.05% |
161,125
+5,100
| +3% | +$587K |
|
406
CDW
CDW
$17.7B
| $21.3M | 0.05% |
161,400
+1,800
| +1% | +$236K |
|
|
KSU
407
DELISTED
Kansas City Southern
KSU
| $21.2M | 0.05% |
104,000
-900
| -0.9% | -$169K |
|
|
HZAC.U
408
DELISTED
Horizon Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
HZAC.U
| $21.1M | 0.05% |
2,000,000
| – | – |
|
|
MOTV.U
409
DELISTED
Motive Capital Corp Units, each consisting of one Class A ordinary share, and one-third of one redee
MOTV.U
| $21.1M | 0.05% |
+2,000,000
| New | +$20.7M |
|
410
Qorvo
QRVO
$8.41B
| $20.9M | 0.05% |
125,800
-2,100
| -2% | -$309K |
|
411
Inspire Medical Systems
INSP
$1.7B
| $20.7M | 0.05% |
110,000
-5,000
| -4% | -$818K |
|
|
CERN
412
DELISTED
Cerner Corp
CERN
| $20.6M | 0.05% |
263,120
-77,100
| -23% | -$5.71M |
|
413
AvalonBay Communities
AVB
$26.6B
| $20.6M | 0.04% |
128,424
+64,977
| +102% | +$10.3M |
|
414
Gates Industrial Corporation Ltd.
GTES
$7.24B
| $20.5M | 0.04% |
1,604,626
-812,145
| -34% | -$10.2M |
|
415
Comstock Resources
CRK
$3.88B
| $20.4M | 0.04% |
4,679,573
+2,717,373
| +138% | +$13.5M |
|
416
Ventas
VTR
$47.3B
| $20.1M | 0.04% |
409,200
+700
| +0.2% | +$32.4K |
|
417
Howmet Aerospace
HWM
$116B
| $19.9M | 0.04% |
696,374
+39,749
| +6% | +$884K |
|
|
RCHG
418
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
| $19.9M | 0.04% |
+1,950,000
| New | +$19.5M |
|
419
LivaNova
LIVN
$4.17B
| $19.9M | 0.04% |
+300,000
| New | +$16.7M |
|
420
Cooper Companies
COO
$14.3B
| $19.8M | 0.04% |
218,460
-1,472
| -0.7% | -$126K |
|
421
Expedia Group
EXPE
$36.8B
| $19.8M | 0.04% |
149,200
+200
| +0.1% | +$22.5K |
|
422
EVgo
EVGO
$214M
| $19.3M | 0.04% |
+1,800,000
| New | +$18.6M |
|
423
Insulet
PODD
$9.66B
| $19.2M | 0.04% |
+75,000
| New | +$18.6M |
|
424
ProQR Therapeutics
PRQR
$268M
| $19.1M | 0.04% |
4,550,062
| – | – |
|
425
Nexstar Media Group
NXST
$5.74B
| $19.1M | 0.04% |
175,000
+10,000
| +6% | +$976K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.